NCT00104572View on ClinicalTrials.gov

Effects of Aromatase Inhibition Versus Testosterone in Older Men With Low Testosterone: Randomized-Controlled Trial.

PHASE2CompletedINTERVENTIONAL
Enrollment

44

Participants

Timeline

Start Date

March 31, 2004

Primary Completion Date

December 31, 2013

Study Completion Date

January 31, 2015

Conditions
HypogonadismDiabetesSarcopeniaOsteoporosisDepression
Interventions
DRUG

Androgel (Testosterone Gel)

1 mg tablet for 12 months

DRUG

Anastrozole (Aromatase Inhibitor)

DRUG

Placebo tablet

Daily for 12 months

DRUG

Placebo gel

Daily for 12 months

DIETARY_SUPPLEMENT

Calcium Cardone 500mg with vitamin D 400 IU

1 tablet three times a day

Trial Locations (1)

21224

National Institute of Aging, Clinical Research Unit, Baltimore

All Listed Sponsors
lead

National Institute on Aging (NIA)

NIH

NCT00104572 - Effects of Aromatase Inhibition Versus Testosterone in Older Men With Low Testosterone: Randomized-Controlled Trial. | Biotech Hunter | Biotech Hunter